GC
CASC

Guggenheim Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Guggenheim Capital’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,668
Closed -$37K – 3067
2015
Q2 		$37K Sell
1,668
-554
-25% -$12.3K ﹤0.01% 2968
2015
Q1 		$22K Buy
2,222
+222
+11% +$2.2K ﹤0.01% 2985
2014
Q4 		$23K Buy
+2,000
New +$23K ﹤0.01% 2954